tirzepatide vs semaglutide weight loss trials semaglutide: A new battle in obesity treatment Tirzepatide vs. Semaglutide in Obesity

Mazdutide is an investigational therapy currently in clinical trials, functioning as a dual GLP-1 and glucagon receptor agonist designed to reduce appetite while increasing energy expenditure

Cases with cardiovascular, respiratory, hematological and/or liver failure have been reported and fatalities attributed to brain edema and multi-organ failure [4]

The body can produce L-Carnitine from the amino acids lysine and methionine, though it's also obtained through diet, especially from meat and dairy products

The right panel highlights that patients with dysglycaemia have a higher risk of new events after PCI and points to the importance of optimal long-term control of dysglycaemia as well as other risk factors post PCI